Literature DB >> 27123134

Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro.

Yusheng Wang1, L E Sun1.   

Abstract

The present study aimed to confirm the promotion of microRNA (miR)-155 expression by latent membrane protein 1 (LMP1), and to recognize the oncogenic role of LMP1 and LMP1-promoted miR-155 in nasopharyngeal carcinoma (NPC), particularly the influence of miR-155 knockdown on the radiosensitivity of CNE-2 cells. Following the regulation of the levels of LMP1 or miR-155 and/or subsequent to radiation treatment, the proliferation ability of CNE-2 cells was examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, colony formation and Cell Counting Kit-8 assays. The results demonstrated that miR-155 was upregulated by overexpression of LMP1 in CNE-2 cells, and LMP1 overexpression and miR-155 mimic transfection increased CNE-2 cell proliferation, whereas miR-155 knockdown attenuated the promotion of CNE-2 cell growth induced by LMP1 overexpression. Furthermore, knockdown of miR-155 enhanced the radiosensitivity of CNE-2 cells. In conclusion, the present study confirmed the oncogenic role of miR-155 in NPC, and demonstrated that knockdown of miR-155 inhibited the growth of NPC cells and sensitized NPC cells to radiotherapy.

Entities:  

Keywords:  latent membrane protein 1; microRNA-155; nasopharyngeal carcinoma; radiotherapy

Year:  2016        PMID: 27123134      PMCID: PMC4841109          DOI: 10.3892/ol.2016.4400

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis.

Authors:  Yi Zhao; Yan Wang; Shan Zeng; Xinrong Hu
Journal:  J Clin Pathol       Date:  2011-10-29       Impact factor: 3.411

3.  A genome-wide identification and characterization of mircoRNAs and their targets in 'Suli' pear (Pyrus pyrifolia white pear group).

Authors:  Qingfeng Niu; Minjie Qian; Guoqin Liu; Fengxia Yang; Yuanwen Teng
Journal:  Planta       Date:  2013-09-08       Impact factor: 4.116

4.  miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.

Authors:  Juan Lu; Huanan Luo; Xiong Liu; Ying Peng; Bao Zhang; Lu Wang; Xia Xu; Xiaohong Peng; Gang Li; Wendong Tian; Ming-Liang He; Hsiangfu Kung; Xiang-Ping Li
Journal:  Carcinogenesis       Date:  2013-10-29       Impact factor: 4.944

Review 5.  The pivotal role of microRNA-155 in the control of cancer.

Authors:  Zhaolin Chen; Taotao Ma; Cheng Huang; Tingting Hu; Jun Li
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

6.  MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells.

Authors:  Gang Li; Zhengrong Wu; Ying Peng; Xiong Liu; Juan Lu; Lu Wang; Qiuhui Pan; Min-Liang He; Xiang-Ping Li
Journal:  Cancer Lett       Date:  2010-08-21       Impact factor: 8.679

7.  Epstein-Barr virus infection as an epigenetic driver of tumorigenesis.

Authors:  Atsushi Kaneda; Keisuke Matsusaka; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Cancer Res       Date:  2012-07-03       Impact factor: 12.701

8.  GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese.

Authors:  Xiuchan Guo; Stephen J O'Brien; Yi Zeng; George W Nelson; Cheryl A Winkler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

9.  Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.

Authors:  Yi-Jun Hua; Fei Han; Li-Xia Lu; Hai-Qiang Mai; Xiang Guo; Ming-Huang Hong; Tai-Xiang Lu; Chong Zhao
Journal:  Eur J Cancer       Date:  2012-07-25       Impact factor: 9.162

10.  Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.

Authors:  Jian Min Tang; Xiu Mei Ma; Yan Li Hou; Li Yan Dai; Hong Bin Cao; Ming Ye; Yong Rui Bai
Journal:  J Radiat Res       Date:  2014-03-09       Impact factor: 2.724

View more
  4 in total

Review 1.  The Advances in Epigenetics for Cancer Radiotherapy.

Authors:  Yuexuan Wang; Yu Han; Yuzhen Jin; Qiang He; Zhicheng Wang
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 2.  miRNAs: micro-managers of anticancer combination therapies.

Authors:  Judy R van Beijnum; Elisa Giovannetti; Dennis Poel; Patrycja Nowak-Sliwinska; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2017-05-04       Impact factor: 9.596

Review 3.  miRNAs in Normal and Malignant Hematopoiesis.

Authors:  Ryutaro Kotaki; Ryo Koyama-Nasu; Natsuko Yamakawa; Ai Kotani
Journal:  Int J Mol Sci       Date:  2017-07-11       Impact factor: 5.923

4.  In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma.

Authors:  Qing Ye; Jing Li; Xiaoyan Wang; Xianzeng Zhang; Jun Lin; Yuting Huo; Zhengzhen Sun; Shusen Xie; Zheng Huang
Journal:  Braz J Otorhinolaryngol       Date:  2019-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.